ABSTRACT
Background The COVID-19 pandemic has led to widespread public health measures to reduce transmission, morbidity, and mortality attributed to the SARS-CoV-2 virus. While much research and focus surrounds COVID-19 vaccine development, testing, and supportive management, little is known about the determinants of non-medical, personal impact of COVID-19 prevention policies. We aimed to understand determinants of non-medical COVID-19 impact and to account for its multileveled, intersectional nature of associations.
Methods This cross-sectional, multi-level, convergent mixed-methods study assessed a range of beliefs, practices, and experiences relating to COVID-19. We recruited a global sample (n=7,411) using both Facebook and Amazon mTURK platforms. We constructed a novel data-driven non-medical COVID-19 Impact Score and four subcomponents (“Personal Action,” “Supply-related,” “Cancellations,” and “Livelihood” impacts). We used generalized estimating equation models with identity link functions to determine concomitant association of individual, household, and country-level variables on the impact scores. We also classified 20,015 qualitative excerpts from 6859 respondents using an 80-code codebook.
Results Total and component impact scores varied significantly by region with Asia, Africa, and Latin America and the Caribbean observing the highest impact scores. Multilevel modeling indicated that individual-level sociocultural variables accounted for much of this variation with COVID-related worry, knowledge, struggles in accessing food and supplies, and worsening mental health most strongly associated with non-medical impact. Family responsibilities, personal COVID medical experience, and health locus of control – in addition to country-level variables reflecting social and health challenge – were also significantly and independently associated with non-medical impact.
Discussion Non-medical personal impact of COVID-19 affects most people internationally, largely in response to shutdowns, implementing prevention requirements, and through economic consequences. In the context where most of the world’s population does not have direct medical experience with COVID-19, this phenomena of non-medical impact is profound, and likely impacts sustainability of public health interventions aimed at containing COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by The Richard W. and Mae Stone Goode Foundation, Award # 057843-002. Dr. Sharma is a trainee in the University of Rochester Translational Biomedical Science PhD Program, which is supported by Grant 2TL1TR002000-05 from the National Center For Advancing Translational Sciences, National Institutes of Health. Additionally, Dr. Siddiqi and Dr. Panko are supported by the National Institute of General Medical Sciences of the National Institute of Health under Award Number K12GM106997. We also accessed the recruitment and REDCap resources of the University of Rochester CTSA, award number UL1 TR002001 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was performed in accordance with the ethical standards established by the 1964 Declaration of Helsinki and its later amendments. The University of Rochester Research Subjects Review Board determined that this study met federal and University criteria for exemption (STUDY00004825). Respondents consented to participate in this research after a review of a detailed Information Sheet presented at the beginning of the REDCap survey and a confirmation of country of residence. Leaving any question they wished unanswered was allowed.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This work was presented, in part, at the 2020 Annual Meeting of the American College of Epidemiology.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos